Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Alternative splicing of the human glucocorticoid receptor (hGR) pre-mRNA generates two highly homologous isoforms, termed hGR alpha and hGR beta. hGR alpha is a ligand-activated transcription factor which, in the hormone-bound state, modulates the expression of glucocorticoid-responsive genes by binding to specific glucocorticoid response element (GRE) DNA sequences. In contrast, hGR beta does not bind glucocorticoids and is transcriptionally inactive. We demonstrate here that hGR beta is able to inhibit the effects of hormone-activated hGR alpha on a glucocorticoid-responsive reporter gene in a concentration-dependent manner. [3H]-Dexamethasone binding studies indicate that hGR beta does not alter the affinity of hGR alpha for its hormonal ligand. The presence of hGR beta in nuclear extracts and its ability to bind to a radiolabeled GRE oligonucleotide suggest that its inhibitory effect may be due to competition for GRE target sites. Reverse transcription-PCR analysis shows expression of hGR beta mRNA in multiple human tissues. These results indicate that hGR beta may be a physiologically and pathophysiologically relevant endogenous inhibitor of glucocorticoid action, which may participate in defining the sensitivity of target tissues to glucocorticoids. They also underline the importance of distinguishing between the two receptor isoforms in all future studies of hGR function and the need to revisit old data.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These GR variants are derived from a single gene by alternative splicing and alternative translation initiation mechanisms.”
From Corticosteroids (2016) · cites this paper as [43]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Exon 2 forms the N-terminal domain of GR, exon 3–4 constitute the central DBD, while exons 5–9 code for the hinge and ligand-binding domain.”
From Corticosteroids (2016) · cites this paper as [43]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Alternative splicing at exon 9 of primary GR transcript generates two highly homologous mRNA transcripts that results in the production of two GR isoforms termed GRα and GRβ (Fig.3A)43, 44.”
From Corticosteroids (2016) · cites this paper as [43]
In the citing paper
“The conventional belief that glucocorticoids act through a single GR protein has changed dramatically with the discovery of a diverse collection of receptor isoforms.”
From Corticosteroids (2016) · cites this paper as [43]
In the citing paper
“The GR protein is encoded by the Nr3c1 gene and consists of 9 exons; exon 1 forms the 5’-untranslated region, while exon 2–9 code for the GR protein.”
From Corticosteroids (2016) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular cloning: A laboratory manual
Deininger, P. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,682
The Steroid and Thyroid Hormone Receptor Superfamily
Evans, R. M. (1988) · Science · doi:10.1126/science.3283939 · Cited by 7,439 · cited 1×
“receptor complex with other DNA elements and/or nuclear proteins then modulate the rate at which these genes are transcribed (6-8).”
BackgroundLipofection: a highly efficient, lipid-mediated DNA-transfection procedure.
Felgner, P. L., Gadek, T. R., Holm, M., Roman, R., Chan, H. W., Wenz, M., Northrop, J. P., Ringold, G. M., & Danielsen, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7413 · Cited by 4,978
Schreiber, E., Matthias, P., Müller, M. M., & Schaffner, W. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.15.6419 · Cited by 4,179 · cited 1×
“48 h after transfection, cells were washed twice with PBS, and nuclear extracts were prepared essentially as described elsewhere (18).”
MethodThe Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated Inflammation
Chrousos, G. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322008 · Cited by 2,579
Self-citationSTEROID RECEPTOR REGULATED TRANSCRIPTION OF SPECIFIC GENES AND GENE NETWORKS
Yamamoto, K. R. (1985) · Annual Review of Genetics · doi:10.1146/annurev.ge.19.120185.001233 · Cited by 1,872
Primary structure and expression of a functional human glucocorticoid receptor cDNA
Hollenberg, S. M., Weinberger, C., Ong, E. S., Cerelli, G., Oro, A., Lebo, R., Brad Thompson, E., Rosenfeld, M. G., & Evans, R. M. (1985) · Nature · doi:10.1038/318635a0 · Cited by 1,869 · cited 3×
“This difference renders hGRJ3 unable to bind glucocorticoid hormones and to be transcriptionally active (9, 11-14).”
BackgroundJonat, C., Rahmsdorf, H. J., Park, K.-K., Cato, A. C. B., Gebel, S., Ponta, H., & Herrlich, P. (1990) · Cell · doi:10.1016/0092-8674(90)90395-u · Cited by 1,566 · cited 1×
“Formation of non-GRE/DNA-binding complexes with the glucocorticoid receptor is believed to be the predominant mechanism by which previously described inhibitors of glucocorticoid action, such as c-jun (23-25), calreticulin (26, 27), and”
BackgroundYang-Yen, H.-F., Chambard, J.-C., Sun, Y.-L., Smeal, T., Schmidt, T. J., Drouin, J., & Karin, M. (1990) · Cell · doi:10.1016/0092-8674(90)90396-v · Cited by 1,553
Functional inactivation of genes by dominant negative mutations
Herskowitz, I. (1987) · Nature · doi:10.1038/329219a0 · Cited by 1,160 · cited 1×
“its transcriptionally active counterpart, and, therefore, fits the definition of a dominant negative inhibitor of hGRa (20).”
BackgroundRay, A., & Prefontaine, K. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.752 · Cited by 1,064
Functional domains of the human glucocorticoid receptor
Giguère, V., Hollenberg, S. M., Rosenfeld, M. G., & Evans, R. M. (1986) · Cell · doi:10.1016/0092-8674(86)90339-9 · Cited by 918 · cited 4×
“This difference renders hGRJ3 unable to bind glucocorticoid hormones and to be transcriptionally active (9, 11-14).”
BackgroundInfluentialSteroid Hormone Receptors: Interaction with Deoxyribonucleic Acid and Transcription Factors*
TRUSS, M., & BEATO, M. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-4-459 · Cited by 741 · cited 2×
“receptor complex with other DNA elements and/or nuclear proteins then modulate the rate at which these genes are transcribed (6-8).”
BackgroundPratt, W. B. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80556-0 · Cited by 653
Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines.
Brasier, A. R., Tate, J. E., & Habener, J. F. (1989) · PubMed · Cited by 596
Steroid hormone receptors compete for factors that mediate their enhancer function
Meyer, M.-E., Gronemeyer, H., Turcotte, B., Bocquel, M.-T., Tasset, D., & Chambon, P. (1989) · Cell · doi:10.1016/0092-8674(89)90918-5 · Cited by 566 · cited 2×
“represent an example for this type of inhibition (29).”
BackgroundSteroid receptors and their associated proteins
Smith, D. F. (1993) · Molecular Endocrinology · doi:10.1210/me.7.1.4 · Cited by 545 · cited 1×
“two molecules of hsp 90, and one molecule each of hsp 70, hsp 56, and hsp 26 (2-5).”
BackgroundNuclear Receptor/AP-1 Interaction*
PFAHL, M. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-5-651 · Cited by 446
Koenig, R. J., Lazar, M. A., Hodin, R. A., Brent, G. A., Larsen, P. R., Chin, W. W., & Moore, D. D. (1989) · Nature · doi:10.1038/337659a0 · Cited by 430
Sher, E. R., Leung, D. Y., Surs, W., Kam, J. C., Zieg, G., Kamada, A. K., & Szefler, S. J. (1994) · Journal of Clinical Investigation · doi:10.1172/jci116963 · Cited by 393 · cited 1×
“From a pathophysiologic perspective, abnormally high expression levels of hGR,3 may participate in the as yet unexplained phenomena of tissue-specific and/or aquired glucocorticoid resistance, such as that observed in rheumatoid arthritis and other autoimmune disorders (13, 37), degenerative osteoarthritis (38), stero…”
BackgroundModulation of gene expression by calreticulin binding to the glucocorticoid receptor
Burns, K., Duggan, B., Atkinson, E. A., Famulski, K. S., Nemer, M., Bleackley, R. C., & Michalak, M. (1994) · Nature · doi:10.1038/367476a0 · Cited by 393
The genomic structure of the human glucocorticoid receptor.
Encío, I. J., & Detera-Wadleigh, S. D. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)89627-6 · Cited by 392
Inhibition of nuclear hormone receptor activity by calreticulin
Dedhar, S., Rennie, P. S., Shago, M., Hagesteijn, C.-Y. L., Yang, H., Filmus, J., Hawley, R. G., Bruchovsky, N., Cheng, H., Matusik, R. J., et al. (1994) · Nature · doi:10.1038/367480a0 · Cited by 375 · cited 1×
“Formation of non-GRE/DNA-binding complexes with the glucocorticoid receptor is believed to be the predominant mechanism by which previously described inhibitors of glucocorticoid action, such as c-jun (23-25), calreticulin (26, 27), and”
BackgroundHurley, D. M., Accili, D., Stratakis, C. A., Karl, M., Vamvakopoulos, N., Rorer, E., Constantine, K., Taylor, S. I., & Chrousos, G. P. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115046 · Cited by 370 · cited 2×
“This difference renders hGRJ3 unable to bind glucocorticoid hormones and to be transcriptionally active (9, 11-14).”
BackgroundSelf-citationSteroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors
Truss, M. (1993) · Endocrine Reviews · doi:10.1210/er.14.4.459 · Cited by 267
Hodin, R. A., Lazar, M. A., & Chin, W. W. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114398 · Cited by 253
Karl, M., Lamberts, S. W., Detera-Wadleigh, S. D., Encio, I. J., Stratakis, C. A., Hurley, D. M., Accili, D., & Chrousos, G. P. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.3.8445027 · Cited by 241 · cited 2×
“This difference renders hGRJ3 unable to bind glucocorticoid hormones and to be transcriptionally active (9, 11-14).”
BackgroundSelf-citationSyndromes of Glucocorticoid Resistance
Chrousos, G. P., Detera-Wadleigh, S. D., & Karl, M. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-11-199312010-00009 · Cited by 235 · cited 5×
“From a pathophysiologic perspective, abnormally high expression levels of hGR,3 may participate in the as yet unexplained phenomena of tissue-specific and/or aquired glucocorticoid resistance, such as that observed in rheumatoid arthritis and other autoimmune disorders (13, 37), degenerative osteoarthritis (38), stero…”
BackgroundSelf-citationWIKSTRÖM, A.-C., BAKKE, O., OKRET, S., BRÖNNEGÅRD, M., & GUSTAFSSON, J.-Å. (1987) · Endocrinology · doi:10.1210/endo-120-4-1232 · Cited by 192
Sanchez, E. R., Hirst, M., Scherrer, L. C., Tang, H. Y., Welsh, M. J., Harmon, J. M., Simons, S. S., Ringold, G. M., & Pratt, W. B. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30478-7 · Cited by 181
Cortisol resistance in acquired immunodeficiency syndrome
Norbiato, G. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.74.3.608 · Cited by 131 · cited 1×
“From a pathophysiologic perspective, abnormally high expression levels of hGR,3 may participate in the as yet unexplained phenomena of tissue-specific and/or aquired glucocorticoid resistance, such as that observed in rheumatoid arthritis and other autoimmune disorders (13, 37), degenerative osteoarthritis (38), stero…”
BackgroundBresnick, E. H., John, S., Berard, D. S., LeFebvre, P., & Hager, G. L. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.10.3977 · Cited by 130
Lazar, M. A., Hodin, R. A., & Chin, W. W. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.20.7771 · Cited by 128
Steroid Receptor Regulated Transcription of Specific Genes and Gene Networks
Yamamoto, K. (1985) · Annual Review of Genetics · doi:10.1146/annurev.genet.19.1.209 · Cited by 121
Katz, D., & Lazar, M. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36872-3 · Cited by 120 · cited 4×
“Interestingly, c-erbAa2 also needed to be overexpressed to cause inhibition (21, 30-32).”
BackgroundInfluentialMolecular mechanisms of dominant negative activity by nuclear hormone receptors
Yen, P. M. (1994) · Molecular Endocrinology · doi:10.1210/me.8.11.1450 · Cited by 114 · cited 1×
“, titration of limiting amounts of accessory proteins or coactivators of hGRa, and occupation of DNAtarget sequences by nontransactivating a/f3-heterodimers and/or f3/f3-homodimers (8, 21, 22).”
BackgroundGlucocorticoid receptors in rheumatoid arthritis
Schlaghecke, R., Kornely, E., Wollenhaupt, J., & Specker, C. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780350704 · Cited by 108 · cited 1×
“From a pathophysiologic perspective, abnormally high expression levels of hGR,3 may participate in the as yet unexplained phenomena of tissue-specific and/or aquired glucocorticoid resistance, such as that observed in rheumatoid arthritis and other autoimmune disorders (13, 37), degenerative osteoarthritis (38), stero…”
BackgroundCzar, M. J., Owens-Grillo, J. K., Dittmar, K. D., Hutchison, K. A., Zacharek, A. M., Leach, K. L., Deibel, M. R., & Pratt, W. B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)78104-6 · Cited by 77
Martins, V. R., Pratt, W. B., Terracio, L., Hirst, M. A., Ringold, G. M., & Housley, P. R. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-2-217 · Cited by 70 · cited 1×
“Dissociation from the hsp complex is thought to be the critical step in hormone-induced activation of hGRa (21, 30-32), regardless of whether it is localized in the cytosol as in most cell types (33) or in the nucleus as in this and in previously described cell culture transfection systems (34, 35).”
BackgroundHUTCHISON, K. A., SCHERRER, L. C., CZAR, M. J., STANCATO, L. F., CHOW, Y., JOVE, R., & PRATT, W. B. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb32269.x · Cited by 62 · cited 1×
“two molecules of hsp 90, and one molecule each of hsp 70, hsp 56, and hsp 26 (2-5).”
BackgroundIIDA, S., NAKAMURA, Y., FUJII, H., NISHIMURA, J.-I., TSUGAWA, M., GOMI, M., FUKATA, J., TARUI, S., MORIWAKI, K., & KITANI, T. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-3-729 · Cited by 61
DiBattista, J. A. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.76.5.1128 · Cited by 40 · cited 1×
“From a pathophysiologic perspective, abnormally high expression levels of hGR,3 may participate in the as yet unexplained phenomena of tissue-specific and/or aquired glucocorticoid resistance, such as that observed in rheumatoid arthritis and other autoimmune disorders (13, 37), degenerative osteoarthritis (38), stero…”
BackgroundKatz, D. A., Berrodin, T. J., & Lazar, M. A. (1992) · Molecular Endocrinology · doi:10.1210/mend.6.5.1318505 · Cited by 39 · cited 2×
“Interestingly, c-erbAa2 also needed to be overexpressed to cause inhibition (21, 30-32).”
Background
Cited by
Brain corticosteroid receptor balance in health and disease
de Kloet, E. R., Vreugdenhil, E., Oitzl, M. S., & Joëls, M. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.3.0331 · Cited by 2,614
“In the human brain, GRb mRNA is found in the hypothalamus and the hippocampus (98), but the abundance is only 1% relative to GRa (97).”
BackgroundBrain corticosteroid receptor balance in health and disease
de Kloet, E. R. (1998) · Endocrine Reviews · doi:10.1210/er.19.3.269 · Cited by 2,614
The Corticosteroid Receptor Hypothesis of Depression
Holsboer, F. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00159-7 · Cited by 2,181
“Heterodimerisation of GRb with the transactive GRa results in diminished GRE regulated gene activity (Bamberger et al. 1995).”
BackgroundThe biology of the glucocorticoid receptor: New signaling mechanisms in health and disease
Oakley, R. H., & Cidlowski, J. A. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.09.007 · Cited by 1,068
“Alternative splicing in exon 9 near the end of the GR primary transcript generates two receptor isoforms, termed GRα and GRβ (Figure 4) (53, 54).”
BackgroundDe Bosscher, K., Vanden Berghe, W., & Haegeman, G. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0006 · Cited by 898
Metadata
- Authors
- Bamberger, C. M., Bamberger, A. M., de Castro, M., & Chrousos, G. P.
- Affiliations
- National Institutes of Health (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1995-06-01
- Volume
- 95
- Issue
- 6
- Pages
- 2435-2441
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC295915
- OpenAlex
- W1974791065
- Cited by
- 642
- References
- 41
- Citations by year
- 2026: 2 · 2025: 8 · 2024: 9 · 2023: 13 · 2022: 6 · 2021: 13 · 2020: 7 · 2019: 25 · 2018: 21 · 2017: 18 · 2016: 23 · 2015: 21 · 2014: 15 · 2013: 16 · 2012: 18
- FWCI
- 15.18
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- glucocorticoid receptor beta, glucocorticoid receptor alpha, alternative splicing, receptor isoforms, glucocorticoid response element, transcriptional repression, dexamethasone binding, glucocorticoid sensitivity
- MeSH terms
- Animals, Base Sequence, Cells, Cultured, Chlorocebus aethiops, Dexamethasone, DNA-Binding Proteins, Glucocorticoids, Humans, Molecular Sequence Data, Receptors, Glucocorticoid, Recombinant Proteins, Regulatory Sequences, Nucleic Acid, RNA, Messenger, Transcription, Genetic, Gene Expression, Alternative Splicing, DNA Primers, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.